Federal Judge In Hawaii Freezes Trump's New Travel Ban

March 16, 2017

Washington, Mar 16: A federal judge in Hawaii on Wednesday issued a sweeping freeze of President Donald Trump's new executive order hours before it would have temporarily barred the issuance of new visas to citizens of six Muslim-majority countries and suspended the admission of new refugees.

newban

In a blistering 43-page opinion, U.S. District Judge Derrick Watson pointed to Trump's own comments and those of his close advisers as evidence that his order was meant to discriminate against Muslims and declared there was a "strong likelihood of success" that those suing would prove the directive violated the Constitution.

Watson declared that "a reasonable, objective observer - enlightened by the specific historical context, contemporaneous public statements, and specific sequence of events leading to its issuance - would conclude that the Executive Order was issued with a purpose to disfavor a particular religion."

He lambasted the government, in particular, for asserting that because the ban did not apply to all Muslims in the world, it could not be construed as discriminating against Muslims.

"The illogic of the Government's contentions is palpable," Watson wrote. "The notion that one can demonstrate animus toward any group of people only by targeting all of them at once is fundamentally flawed."

At a rally in Nashville, Trump called the ruling "terrible" and asked a cheering crowd whether the ruling was "done by a judge for political reasons." He said the administration would fight the case "as far as it needs to go," including up to the Supreme Court, and rued that he had been persuaded to sign a "watered-down version" of his first travel ban.

"Let me tell you something, I think we ought to go back to the first one and go all the way," Trump said. "The danger is clear, the law is clear, the need for my executive order is clear."

Sarah Isgur Flores, a spokeswoman for the Justice Department, said in a statement: "The Department of Justice strongly disagrees with the federal district court's ruling, which is flawed both in reasoning and in scope. The President's Executive Order falls squarely within his lawful authority in seeking to protect our Nation's security, and the Department will continue to defend this Executive Order in the courts."

Watson was one of three federal judges to hear arguments Wednesday about the ban, though he was the first to issue an opinion. Federal judges in Washington state and Maryland said they would issue opinions soon.

As the ruling in Hawaii was being handed down, James Robart, the federal judge in Washington state who froze Trump's first travel ban, was hearing arguments about whether he should freeze the second. He said he did not think his first freeze was still in effect, though he did not immediately rule on whether he should issue a new one.

Watson's decision might not be the last word. He was considering only a request for a temporary restraining order, and while that required him to assess whether challengers of the ban would ultimately succeed, his ruling is not final on that question. The Justice Department could appeal the ruling or wage a longer-term court battle before the judge in Hawaii.

Watson's decision came in response to a lawsuit filed by Hawaii. Lawyers for the state alleged that the new entry ban, much like the old, violated the establishment clause of the First Amendment because it was essentially a Muslim ban, hurt the ability of state businesses and universities to recruit top talent, and damaged the state's robust tourism industry.

They pointed to the case of Ismail Elshikh, the imam of the Muslim Association of Hawaii, whose mother-in-law's application for an immigrant visa was still being processed. Under the new executive order, attorneys for Hawaii said, Elshikh feared that his mother-in-law, a Syrian national, would ultimately be banned from entering the United States.

"Dr. Elshikh certainly has standing in this case. He, along with all of the Muslim residents in Hawaii, face higher hurdles to see family because of religious faith," lawyer Colleen Roh Sinzdak said at a hearing Wednesday. "It is not merely a harm to the Muslim residents of the state of Hawaii, but also is a harm to the United States as a whole and is against the First Amendment itself."

Elshikh is a U.S. citizen of Egyptian descent who has been a resident of Hawaii for over a decade. His wife is of Syrian descent and is also a resident of Hawaii.

Justice Department lawyers argued that Trump was well within his authority to impose the ban, which was necessary for national security, and that those challenging it had raised only speculative harms. "They bear the burden of showing irreparable harm . . . and there is no harm at all," said the acting U.S. solicitor general, Jeffrey Wall, who argued on behalf of the government in Greenbelt, Md., in the morning and by phone in Hawaii in the afternoon.

Watson agreed with the state on virtually all the points. He ruled that the state had preliminarily demonstrated its universities and tourism industry would be hurt, and that harm could be traced to the executive order. He wrote that Elshikh had alleged "direct, concrete injuries to both himself and his immediate family."

And Watson declared that the government's assertion of the national security need for the order was "at the very least, 'secondary to a religious objective' of temporarily suspending the entry of Muslims." He pointed to Trump's own campaign trail comments and public statements by advisers as evidence.

"For instance, there is nothing 'veiled' about this press release: 'Donald J. Trump is calling for a total and complete shutdown of Muslims entering the United States,' " Watson wrote. "Nor is there anything 'secret' about the Executive's motive specific to the issuance of the Executive Order. Rudolph Giuliani explained on television how the Executive Order came to be. He said: 'When [Mr. Trump] first announced it, he said, 'Muslim ban.' He called me up. He said, 'Put a commission together. Show me the right way to do it legally.' "

Watson also pointed to a recent Fox News appearance by Stephen Miller, in which the president's senior policy adviser said the new ban would have "mostly minor technical differences" from the previous iteration frozen by the courts, and Americans would see "the same basic policy outcome for the country."

"These plainly-worded statements, made in the months leading up to and contemporaneous with the signing of the Executive Order, and, in many cases, made by the Executive himself, betray the Executive Order's stated secular purpose," Watson wrote.

Opponents of the ban across the country - including those who had argued against it in different cases on Wednesday - hailed Watson's ruling.

Bob Ferguson, the Washington state attorney general who asked Robart to block the measure, called the Hawaii ruling "fantastic news." Justin Cox, a staff attorney for the National Immigration Law Center who argued for a restraining order in the case in Maryland, said, "This is absolutely a victory and should be celebrated as such, especially because the court held that the plaintiffs, that Hawaii was likely to succeed on its establishment clause claim which essentially is that the primary purpose of the executive order is to discriminate against Muslims."

Cox said while the judge did not halt the order entirely, he blocked the crucial sections - those halting the issuance of new visas and suspending the refugee program. Left intact, Cox said, were lesser-known provisions, including one that orders Homeland Security and the U.S. attorney general to publicize information about foreign nationals charged with terrorism-related offenses and other crimes. He said the provision seems designed to whip up fear of Muslims.

"It's a shaming device that it's really a dehumanizing device," he said. "It perpetuates this myth, this damaging stereotype of Muslims as terrorists."

Trump's new entry ban had suspended the U.S. refugee program for 120 days and halted for 90 days the issuance of new visas to people from six Muslim-majority countries: Iran, Somalia, Sudan, Yemen, Libya and Syria. It was different from the first entry ban in that it omitted Iraq from the list of affected countries, did not affect current visa or green-card holders and spelled out a robust list of people who might be able to apply for exceptions.

The administration could have defended the first ban in court - though it chose instead to rewrite the president's executive order in such a way that it might be more defensible. The next step might have been to persuade the U.S. Court of Appeals for the 9th Circuit to rehear the case en banc, after a three-judge panel with the court upheld the freeze on Trump's ban.

Hawaii is a part of the 9th Circuit, so the legal road could pass through the appeals court there again. Perhaps previewing the contentious fight ahead, five of the circuit's judges on Wednesday signed a dissenting opinion in the case over the original travel ban, declaring Trump's decision to issue the executive order was "well within the powers of the presidency." The judges wanted to wipe out a ruling by a three-judge panel declaring otherwise.

"Above all, in a democracy, we have the duty to preserve the liberty of the people by keeping the enormous powers of the national government separated," Judge Jay S. Bybee wrote for the dissenters. "We are judges, not Platonic Guardians. It is our duty to say what the law is, and the meta-source of our law, the U.S. Constitution, commits the power to make foreign policy, including the decisions to permit or forbid entry into the United States, to the President and Congress."

The dissent was signed by Judges Bybee, Sandra Ikuta, Consuelo Callahan and Carlos Bea, who all were appointed by President George W. Bush; and Judge Alex Kozinski, who was appointed by President Ronald Reagan. It seemed to represent a minority view. The circuit has 25 active judges, and the court said a majority had not voted in favor of reconsidering the three-judge panel's published opinion to keep Trump's first ban frozen.

That opinion was signed by Judges Michelle Friedland, who was appointed by President Barack Obama; Richard Clifton, who was appointed by President George W. Bush; and Judge William Canby Jr. and Judge Stephen Reinhardt formally joined their opinion Wednesday and remarked that only a "small number" of 9th Circuit judges wanted to overturn it.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 21,2020

Canberra, May 21: Australian Prime Minister Scott Morrison and his Indian counterpart, Narendra Modi, are looking forward to deepening the countries' strategic relationship, with both sides expected to sign a range of pacts from defence to trade in strategic sectors amid heightened tensions with China over Beijing's response to coronavirus pandemic.

During a virtual summit, scheduled to take place on June 4, both leaders are expected to ramp up efforts to diversify Australia's export markets and find trusted suppliers of vital products and components, a local newspaper, The Australian reported on Tuesday.

The new agreements will focus on reliable supply chains in key strategic sectors, including medical goods, technology and critical minerals, amid heightened tensions with China over Beijing's response to coronavirus pandemic.

The leaders will seal a new defence agreement allowing reciprocal access to bases and co-operation on military technology projects, while a new education partnership will be on the table to help overcome Australian university reliance on Chinese students.

The talks in terms of strategic convergence, now have greater significance as COVID-19 exacerbates the strategic contest between the US and China, and forces like-minded countries to seek out reliable partners.

Australian farmers could also benefit, with talks underway on expanding agricultural exports to India, including barley, as China throws up new trade barriers, media reports stated.

The virtual summit follows the cancellation of Morrison's planned state visit to India in January due to the bushfires.

Morrison said last year, ahead of his planned visit, that India was "a natural partner for Australia", referring to the countries' "shared values" -- a point of differentiation with China.

Former Department of Foreign Affairs and Trade secretary Peter Varghese, who wrote a landmark report on the bilateral relationship in 2018, was quoted by the newspaper as saying that India would be even more important to Australia in the post-COVID world. "If one of the lessons from COVID is that countries need to spread their risk, then finding new markets or building up existing markets is a crucial part of that," he added.

Varghese noted that India, a member of the Quadrilateral Security Dialogue along with Australia, Japan and the US, was a vital strategic partner to Australia in helping "constrain China's ambitions to be the predominant power".

"That shared objective between Australia and India of not wanting to see the region dominated by China is a key component of building up our geopolitical relationship," he told The Australian.

The summit also follows recent talks between Australian Foreign Minister Marise Payne and Indian counterpart Subrahmanyam Jaishankar on the pandemic response and Australia's call for an independent inquiry, which was overwhelmingly backed at the World Health Assembly on Tuesday.

Australia wants to support India to develop a domestic critical minerals processing industry, which would provide Western nations with an alternative to sourcing the materials from China.

Meanwhile, India has strong expertise as a manufacturer of drugs and medical equipment, while Australia is a centre of biomedical research, opening the possibility for closer co-operation in the key sector, the media reported further.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 20,2020

Washington, May 20: Once dubbed as historic by him, US President Donald Trump on Tuesday said he now feels ‘differently’ about the trade deal he signed with China earlier this year.

He said this while once again venting out his frustration with the Beijing leadership, accusing it of letting coronavirus spread.

Till Tuesday, over 92,000 Americans have died and 1.5 million tested positive for coronavirus that has globally killed around 320,000 people.

The US and China had signed a deal in January to end their 22-month-long trade war during which the two countries slapped tit-for-tat tariff hikes on products worth nearly half a trillion USD.

Under it, Beijing agreed to increase its purchase of US goods by USD 200 billion in 2020-2021.

“I feel differently now about that deal than I did three months ago,” Trump told reporters during a Cabinet meeting at the White House.

“We will see what all happens, but it's been a very disappointing situation. A very disappointing thing happened with China because the plague flowed in and that wasn't supposed to happen and it could have been stopped," he said.

Trump said he was very excited when the trade deal with China was signed.

“But once the virus came in, once the plague, as I called it, came in, I said how did they let that happen? And how come it didn't go into other sections of China? Why did they block it from leaving Wuhan? But they didn't block it from going to the rest of the world, including the United States. Why is that? Beijing doesn't have it. Other places don't have it,” he said.

Trump did not respond to questions on retaliation against China.

Meanwhile, top American senators continued to press the administration that rules of engagement with China needs to change post-coronavirus.

“As we know, they unleashed this virus on America and the world with their classic communist cover-up, deception, continued propaganda campaign, costing now over 90,000 American lives, 35 million Americans losing their jobs so far,” Senator Martha McSally said during a Congressional hearing.

“We don’t know who patient zero is, they destroyed samples, they silenced doctors, they kicked out journalists, they impacted international travel to seed this and their reckless behaviour continues to be the root of all this,” she said.

As a result of coronavirus, the American economy has been thrown into recession; more than 36 million people have lost their job – the worst ever after last century’s great depression.

Many of the US states have now started opening up, after taking necessary precautions.

By conservative estimates, it will take several quarters for the economy to be back on track.

Trump in the last a few weeks has exuded confidence that the economy will be back on track next year.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 4,2020

Jun 4: A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in people in close contact with someone with the disease.

Results published Wednesday by the New England Journal of Medicine show that hydroxychloroquine was no better than placebo pills at preventing illness from the coronavirus.

The drug did not seem to cause serious harm, though -- about 40% on it had side effects, mostly mild stomach problems.

 “We were disappointed. We would have liked for this to work,” said the study leader, Dr. David Boulware, an infectious disease specialist at the University of Minnesota.

“But our objective was to answer the question and to conduct a high-quality study,” because the evidence on the drug so far has been inconclusive, he said.

Hydroxychloroquine and a similar drug, chloroquine, have been the subject of much debate since Trump started promoting them in March.

Hydroxychloroquine has long been used for malaria, lupus, and rheumatoid arthritis, but no large studies have shown it or chloroquine to be safe or effective for much sicker patients with coronavirus, and some studies have suggested the drugs may do harm.

Trump took a two-week course of hydroxychloroquine, along with zinc and Vitamin D, after two staffers tested positive for COVID-19, and had no ill effects, according to results of his latest physical released by his doctor Wednesday.

Federal regulators have warned against hydroxychloroquine's use except in hospitals and formal studies because of the risk of side effects, especially heart rhythm problems.

Boulware's study involved 821 people in the United States and Canada living with someone diagnosed with COVID-19 or at high risk of getting it because of their job -- doctors, nurses, ambulance workers who had significant exposure to a sick patient while not wearing full protective gear.

They were randomly assigned to get either the nutrient folate as a placebo or hydroxychloroquine for five days, starting within four days of their exposure. Neither they nor others involved in the research knew who was getting which pills.

After 14 days in the study, 12 per cent on the drug developed COVID-19 symptoms versus 14 per cent in the placebo group, but the difference is so small it could have occurred by chance, Boulware said.

“There's basically no effect. It does not prevent infection,” he said of the drug. Even if it were to give some slim advantage, “we'd want a much larger effect” to justify its use and risk of side effects for preventing illness, he said.

Results were no different among a subgroup of participants who were taking zinc or vitamin C, which some people believe might help make hydroxychloroquine more effective or fight the coronavirus.

There are some big caveats: The study enrolled people through the Internet and social media, relying on them to report their own symptoms rather than having them tracked in a formal way by doctors.

Participants were not all tested for the coronavirus but were diagnosed as COVID-19 cases based on symptoms in many cases. And not all took their medicines as directed.

The results “are more provocative than definitive,” and the drug may yet have prevention benefits if tried sooner or in a different way, Dr. Myron Cohen of the University of North Carolina at Chapel Hill wrote in a commentary in the journal.

Others were glad to see a study that had a comparison group and good scientific methods after so many weaker reports on hydroxychloroquine.

“This fits with everything else we've seen so far which suggests that it's not beneficial," said Dr. Peter Bach, director of a health policy center at Memorial Sloan Kettering Cancer Center in New York.

This study was in younger relatively healthy people, but the results “would make me very discouraged about trying to use this in older people” who are most vulnerable to serious illness from the coronavirus, Bach said.

“If it does work, it doesn't work very well.” Dr. Dan Culver, a lung specialist at the Cleveland Clinic, said there's still a chance that giving the drug sooner than four days after someone's exposure to the virus may help prevent illness.

But the study “takes 'home run' off the table” as far as hopes for the drug, he said.

The study was mostly funded by David Baszucki, founder of Roblox, a California-based game software company, and other private donors and the Minnesota university.

Boulware also is leading a study testing hydroxychloroquine for treating COVID-19. The study is finished and results are being analyzed now.

On Tuesday, the journal Lancet posted an “expression of concern” about a study it published earlier this month of nearly 15,000 COVID-19 patients on the malaria drugs that tied their use to a higher risk of dying in the hospital or developing a heartbeat problem.

Scientists have raised serious questions about the database used for that study, and its authors have launched an independent audit.

That work had a big impact: the World Health Organization suspended use of hydroxychloroquine in a study it is leading, and French officials stopped the drug's use in hospitals. On Wednesday, the WHO said experts who reviewed safety information decided that its study could resume.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.